CT
Candor Therapeutics Inc.
SEC filingBiotechnology · Sunnyvale, CA
Amount raised$50Ksold at filing
Total offering$750K$700K still open
Investors in the raise2count reported to the SEC
FiledAug 28, 2026first sale Aug 17, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ramkumar MandalamExecutive Officer, Director
Mohan SrinivasanDirector
Executive officers, directors and promoters as listed on the Form D.